2023 Q4 Form 10-Q Financial Statement

#000121390023088845 Filed on November 20, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2023 Q2
Revenue $0.00 $22.13M $21.60M
YoY Change -100.0% 15.7%
Cost Of Revenue $0.00 $14.13M $13.66M
YoY Change -100.0% 13.24%
Gross Profit $0.00 $7.995M $7.940M
YoY Change -100.0% 20.32%
Gross Profit Margin 36.13% 36.75%
Selling, General & Admin $2.704M $4.307M $2.609M
YoY Change -34.42% 14.65% 13118.46%
% of Gross Profit 53.87% 32.85%
Research & Development $14.22K
YoY Change -75.7%
% of Gross Profit 0.18%
Depreciation & Amortization $0.00 $701.1K $653.0K
YoY Change -100.0% 24.05% 15.58%
% of Gross Profit 8.77% 8.22%
Operating Expenses $2.704M $5.008M $3.330M
YoY Change -34.42% 32.0% 3572.7%
Operating Profit -$2.704M $2.987M $4.610M
YoY Change -149.03% 4.77% -5185.18%
Interest Expense -$137.5K -$1.819M -$1.010M
YoY Change -95.45% 346.03% -104059.16%
% of Operating Profit -60.89% -21.92%
Other Income/Expense, Net -$1.320M $40.20K -$1.757M
YoY Change -58.92% -109.57% 422.88%
Pretax Income -$4.162M $1.859M $2.853M
YoY Change
Income Tax $0.00
% Of Pretax Income 0.0%
Net Earnings -$4.162M $1.859M $2.853M
YoY Change -262.21% -23.53% 1062.24%
Net Earnings / Revenue 8.4% 13.21%
Basic Earnings Per Share $0.02 -$0.01
Diluted Earnings Per Share -$0.04 $0.02 $0.03
COMMON SHARES
Basic Shares Outstanding 126.9M shares 114.9M shares 114.4M shares
Diluted Shares Outstanding 118.6M shares

Balance Sheet

Concept 2023 Q4 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.490K $2.758M $3.211M
YoY Change
Cash & Equivalents $2.492K $1.255M $1.708M
Short-Term Investments $1.503M $1.503M
Other Short-Term Assets $2.354M $7.284M $4.944M
YoY Change -97.87%
Inventory $1.437M $1.536M
Prepaid Expenses
Receivables $72.69M $60.41M
Other Receivables $0.00 $0.00
Total Short-Term Assets $2.357M $127.6M $116.7M
YoY Change -97.89% 240.81% 498285.0%
LONG-TERM ASSETS
Property, Plant & Equipment $32.23M $32.13M
YoY Change
Goodwill $56.39M $56.39M
YoY Change
Intangibles
YoY Change
Long-Term Investments $6.500M
YoY Change
Other Assets $88.52M
YoY Change
Total Long-Term Assets $6.500M $88.61M $88.52M
YoY Change -92.7% 8761.37%
TOTAL ASSETS
Total Short-Term Assets $2.357M $127.6M $116.7M
Total Long-Term Assets $6.500M $88.61M $88.52M
Total Assets $8.857M $216.2M $205.2M
YoY Change -95.59% 462.42% 876348.88%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $166.6K $48.99M $41.01M
YoY Change -99.62%
Accrued Expenses $154.0K $1.207M $2.290M
YoY Change -87.23%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $24.09M $18.91M
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.782M $150.3M $143.6M
YoY Change -96.0% 352.28% 118975.15%
LONG-TERM LIABILITIES
Long-Term Debt $2.331M $13.11M $12.83M
YoY Change
Other Long-Term Liabilities $1.938M $1.938M
YoY Change
Total Long-Term Liabilities $2.331M $27.53M $28.35M
YoY Change -92.0% 2403.06%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.782M $150.3M $143.6M
Total Long-Term Liabilities $2.331M $27.53M $28.35M
Total Liabilities $8.113M $177.8M $172.0M
YoY Change -95.33% 417.99% 142476.43%
SHAREHOLDERS EQUITY
Retained Earnings -$16.63M -$5.761M -$7.455M
YoY Change 76.22% -47.56% -41.25%
Common Stock $127.1K $126.9K $114.6K
YoY Change 23.57% 23.33% 13.57%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $743.5K $38.41M $33.20M
YoY Change
Total Liabilities & Shareholders Equity $8.857M $216.2M $205.2M
YoY Change -95.59% 462.42% 876348.88%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$4.162M $1.859M $2.853M
YoY Change -262.21% -23.53% 1062.24%
Depreciation, Depletion And Amortization $0.00 $701.1K $653.0K
YoY Change -100.0% 24.05% 15.58%
Cash From Operating Activities -$3.654M $2.106M $1.824M
YoY Change 165.49% -1399.94%
INVESTING ACTIVITIES
Capital Expenditures $798.7K -$625.3K
YoY Change 213.23%
Acquisitions
YoY Change
Other Investing Activities -$5.500M
YoY Change
Cash From Investing Activities -$4.622M -$798.7K $625.3K
YoY Change 213.23%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 8.334M -$1.760M -$1.971M
YoY Change 261.22% -1517.29%
NET CHANGE
Cash From Operating Activities -3.654M $2.106M $1.824M
Cash From Investing Activities -4.622M -$798.7K $625.3K
Cash From Financing Activities 8.334M -$1.760M -$1.971M
Net Change In Cash 57.33K -$453.2K $477.9K
YoY Change -991.24% -39498.85%
FREE CASH FLOW
Cash From Operating Activities -$3.654M $2.106M $1.824M
Capital Expenditures $798.7K -$625.3K
Free Cash Flow $1.307M $2.449M
YoY Change 142.88%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 dei Document Type
DocumentType
10-Q
CY2023Q3 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
11906654 usd
CY2023Q3 us-gaap Goodwill
Goodwill
56387027 usd
CY2023Q2 us-gaap Goodwill
Goodwill
56387027 usd
CY2023Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
88613730 usd
CY2023Q3 dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
CY2023Q3 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q3 dei Entity File Number
EntityFileNumber
000-56239
CY2023Q3 dei Entity Registrant Name
EntityRegistrantName
Quality Industrial Corp.
CY2023Q3 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023Q3 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
35-2675388
CY2023Q3 dei Entity Address Address Line1
EntityAddressAddressLine1
315 Montgomery Street
CY2023Q3 dei Entity Address City Or Town
EntityAddressCityOrTown
San Francisco
CY2023Q3 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2023Q3 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94104
CY2023Q3 dei City Area Code
CityAreaCode
800
CY2023Q3 dei Local Phone Number
LocalPhoneNumber
706-0806
CY2023Q3 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q3 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q3 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q3 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q3 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023Q3 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023Q3 dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
126887936 shares
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1254598 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1707801 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
1437330 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
1536283 usd
CY2023Q3 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
36200632 usd
CY2023Q2 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
39974415 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
72693254 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
60408873 usd
CY2023Q3 qind Advances To Sub Contractors
AdvancesToSubContractors
7252919 usd
CY2023Q2 qind Advances To Sub Contractors
AdvancesToSubContractors
6612608 usd
CY2023Q3 us-gaap Deposits Assets Current
DepositsAssetsCurrent
1503279 usd
CY2023Q2 us-gaap Deposits Assets Current
DepositsAssetsCurrent
1503279 usd
CY2023Q3 us-gaap Other Assets Current
OtherAssetsCurrent
7284049 usd
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
4943623 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
127626061 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
116686882 usd
CY2023Q3 qind Property Plant Equipment Non Current
PropertyPlantEquipmentNonCurrent
1490086 usd
CY2023Q2 qind Property Plant Equipment Non Current
PropertyPlantEquipmentNonCurrent
1290081 usd
CY2023Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
1867509 usd
CY2023Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
1667509 usd
CY2023Q3 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
77202 usd
CY2023Q2 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
118193 usd
CY2023Q3 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
16885252 usd
CY2023Q2 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
17146631 usd
CY2023Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
11906654 usd
CY2023Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
88516095 usd
CY2023Q3 us-gaap Assets
Assets
216239791 usd
CY2023Q2 us-gaap Assets
Assets
205202977 usd
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
50192442 usd
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
43299321 usd
CY2023Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
81048020 usd
CY2023Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
81436536 usd
CY2023Q3 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
19055041 usd
CY2023Q2 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
18911641 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
150295503 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
143647498 usd
CY2023Q3 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
2343804 usd
CY2023Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
2070000 usd
CY2023Q3 us-gaap Federal Home Loan Bank Advances Long Term
FederalHomeLoanBankAdvancesLongTerm
10768392 usd
CY2023Q2 us-gaap Federal Home Loan Bank Advances Long Term
FederalHomeLoanBankAdvancesLongTerm
10761062 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
12192300 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
13581728 usd
CY2023Q3 us-gaap Liabilities Other Than Longterm Debt Noncurrent
LiabilitiesOtherThanLongtermDebtNoncurrent
2229218 usd
CY2023Q2 us-gaap Liabilities Other Than Longterm Debt Noncurrent
LiabilitiesOtherThanLongtermDebtNoncurrent
2229218 usd
CY2023Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
27533714 usd
CY2023Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
28642008 usd
CY2023Q3 us-gaap Liabilities
Liabilities
177829217 usd
CY2023Q2 us-gaap Liabilities
Liabilities
172289506 usd
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
126887936 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
126887936 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
114576965 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
114576965 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
126890 usd
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
114579 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
17232706 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
13607017 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5761470 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5801674 usd
CY2023Q3 qind Minority Interests
MinorityInterests
26812448 usd
CY2023Q2 qind Minority Interests
MinorityInterests
24993549 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
38410574 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
32913471 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
216239791 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
205202977 usd
CY2023Q3 us-gaap Revenues
Revenues
22129973 usd
CY2022Q3 us-gaap Revenues
Revenues
19126800 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
14134605 usd
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
12481550 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
7995368 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
6645250 usd
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
19250 usd
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
25450 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4287754 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3203268 usd
CY2023Q3 us-gaap Depreciation
Depreciation
701090 usd
CY2022Q3 us-gaap Depreciation
Depreciation
565170 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
5008094 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
3793888 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
2987274 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
2851362 usd
CY2023Q3 us-gaap Financing Interest Expense
FinancingInterestExpense
1141365 usd
CY2022Q3 us-gaap Financing Interest Expense
FinancingInterestExpense
407800 usd
CY2023Q3 us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
43004 usd
CY2022Q3 us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
12447 usd
CY2023Q3 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
165872 usd
CY2023Q3 us-gaap Other Expenses
OtherExpenses
1350242 usd
CY2022Q3 us-gaap Other Expenses
OtherExpenses
420247 usd
CY2023Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
222071 usd
CY2023Q3 us-gaap Other Income
OtherIncome
222071 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1859103 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
2431116 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
-1818899 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
-1206459 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
40204 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1224657 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
118283503 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
102290302 shares
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
32913471 usd
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2000000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
126000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
1512000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1859103 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
38410574 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
20368861 usd
CY2022Q3 qind Stock Issued During Period Value Goodwill Adjustment
StockIssuedDuringPeriodValueGoodwillAdjustment
3222360 usd
CY2022Q3 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
82600 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
2431116 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
26104937 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
1859103 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
2431116 usd
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
1512000 usd
CY2023Q3 qind Settlement Of Debt
SettlementOfDebt
701090 usd
CY2022Q3 qind Settlement Of Debt
SettlementOfDebt
565107 usd
CY2022Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
243899 usd
CY2023Q3 us-gaap Other Noncash Income Tax Expense
OtherNoncashIncomeTaxExpense
165872 usd
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
1477316 usd
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
420247 usd
CY2023Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-98953 usd
CY2022Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-73054 usd
CY2023Q3 qind Increase Decrease In Workinprogress
IncreaseDecreaseInWorkinprogress
-3773783 usd
CY2023Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
12284381 usd
CY2022Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
18170460 usd
CY2023Q3 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
980737 usd
CY2022Q3 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-321031 usd
CY2023Q3 us-gaap Increase Decrease In Option Premium Contracts Payable
IncreaseDecreaseInOptionPremiumContractsPayable
6732911 usd
CY2022Q3 us-gaap Increase Decrease In Option Premium Contracts Payable
IncreaseDecreaseInOptionPremiumContractsPayable
15257455 usd
CY2023Q3 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
113912 usd
CY2022Q3 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
59511 usd
CY2023Q3 qind Cash Generated From Operations
CashGeneratedFromOperations
3169823 usd
CY2022Q3 qind Cash Generated From Operations
CashGeneratedFromOperations
1200959 usd
CY2023Q3 qind Finance Costs Paid
FinanceCostsPaid
-1064033 usd
CY2022Q3 qind Finance Costs Paid
FinanceCostsPaid
-407800 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2105790 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
793158 usd
CY2023Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
798725 usd
CY2022Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
255000 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-798725 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-255000 usd
CY2023Q3 us-gaap Proceeds From Repayments Of Other Debt
ProceedsFromRepaymentsOfOtherDebt
150730 usd
CY2022Q3 us-gaap Proceeds From Repayments Of Other Debt
ProceedsFromRepaymentsOfOtherDebt
-272307 usd
CY2023Q3 us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
2184802 usd
CY2022Q3 us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
215000 usd
CY2023Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2000000 usd
CY2023Q3 qind Buy Back Commitment
BuyBackCommitment
2000000 usd
CY2023Q3 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
273804 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1760268 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-487307 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-453203 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
50851 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1707801 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1114131 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1254598 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1164982 usd
CY2022Q2 qind Control Block Shares Transferred Shares
ControlBlockSharesTransferredShares
77669078 shares
CY2022Q2 qind Control Block Shares Transferred Value
ControlBlockSharesTransferredValue
500000 usd
CY2023Q3 us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b><i>Use of estimates</i></b> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">A critical accounting estimate is an estimate that: (i) is made in accordance with generally accepted accounting principles, (ii) involves a significant level of estimation uncertainty and (iii) has had or is reasonably likely to have a material impact on the Company’s financial condition or results of operations.</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">The Company’s Consolidated Financial Statements have been prepared in accordance with generally accepted accounting principles in the United States of America (U.S. GAAP). The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and judgments that affect reported amounts and related disclosures. On an ongoing basis, management evaluates and updates its estimates. Management employs judgment in making its estimates but they are based on historical experience and currently available information and various other assumptions that the Company believes to be reasonable under the circumstances. The results of these estimates form the basis for making judgments about the carrying values of assets and liabilities that are not readily available from other sources. Actual results could differ from those estimates. Management believes that its judgment is applied consistently and produces financial information that fairly depicts the results of operations for all periods presented.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Significant estimates include estimates used to review the Company’s, impairments and estimations of long-lived assets, revenue recognition of Contract based revenue, allowances for uncollectible accounts, and the valuations of non-cash capital stock issuances. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable in the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.  Actual results may differ from these estimates under different assumptions or conditions.</p>
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1254598 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1707801 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1859103 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
2431116 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1859103 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2431116 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
118283503 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
102290302 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
118283503 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
102290302 shares
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
118574503 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
102290302 shares
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
333515 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
12192300 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
835943 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
13581728 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1254598 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1707801 usd
CY2023Q3 qind Retention Receivables
RetentionReceivables
2590611 usd
CY2023Q2 qind Retention Receivables
RetentionReceivables
2590611 usd
CY2023Q3 qind Amount Due From Related Party
AmountDueFromRelatedParty
2191608 usd
CY2023Q2 qind Amount Due From Related Party
AmountDueFromRelatedParty
2072077 usd
CY2023Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
63862 usd
CY2023Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
70000 usd
CY2023Q3 qind Buy Back Commitments
BuyBackCommitments
2000000 usd
CY2023Q3 qind Other Current Asset
OtherCurrentAsset
473968 usd
CY2023Q2 qind Other Current Asset
OtherCurrentAsset
210935 usd
CY2023Q3 us-gaap Other Assets Current
OtherAssetsCurrent
7284049 usd
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
4943623 usd
CY2023Q3 us-gaap Payments To Acquire Finance Receivables
PaymentsToAcquireFinanceReceivables
397390 usd
CY2022Q3 us-gaap Payments To Acquire Finance Receivables
PaymentsToAcquireFinanceReceivables
30000 usd
CY2023Q3 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
1000000 usd
CY2023Q3 qind Working Capital
WorkingCapital
100000 usd
CY2023Q3 us-gaap Debt Instrument Redemption Price Percentage Of Principal Amount Redeemed
DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed
0.01 pure
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
72693254 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
60408873 usd
CY2023Q3 us-gaap Accounts Receivable Unapproved Contract Claims
AccountsReceivableUnapprovedContractClaims
30095285 usd
CY2023Q2 us-gaap Accounts Receivable Unapproved Contract Claims
AccountsReceivableUnapprovedContractClaims
30095285 usd
CY2023Q3 us-gaap Accounts Payable Interest Bearing Interest Rate
AccountsPayableInterestBearingInterestRate
0.20 pure
CY2023Q3 us-gaap Investment Company Committed Capital
InvestmentCompanyCommittedCapital
3000000 usd
qind Rightofuse Assets Cost
RightofuseAssetsCost
16639146 usd
CY2022Q2 us-gaap Real Estate Owned Accumulated Depreciation
RealEstateOwnedAccumulatedDepreciation
4244695 usd
CY2022Q2 us-gaap Asset Backed Securities At Carrying Value
AssetBackedSecuritiesAtCarryingValue
12394451 usd
us-gaap Cost Of Goods And Services Sold Depreciation
CostOfGoodsAndServicesSoldDepreciation
487797 usd
CY2022Q4 us-gaap Real Estate Owned Accumulated Depreciation
RealEstateOwnedAccumulatedDepreciation
4732492 usd
CY2022Q4 us-gaap Asset Backed Securities At Carrying Value
AssetBackedSecuritiesAtCarryingValue
11906654 usd
CY2023Q2 us-gaap Asset Backed Securities At Carrying Value
AssetBackedSecuritiesAtCarryingValue
11906654 usd
CY2023Q3 us-gaap Asset Backed Securities At Carrying Value
AssetBackedSecuritiesAtCarryingValue
11906654 usd
CY2022Q4 us-gaap Assets Net
AssetsNet
49255718 usd
CY2023Q3 us-gaap Goodwill
Goodwill
56387027 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
333515 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
835943 usd
CY2023Q3 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
117572 usd
CY2023Q2 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
77093 usd
CY2023Q3 qind Payable To The Shareholders Of The Subsidiary Quality International
PayableToTheShareholdersOfTheSubsidiaryQualityInternational
75500000 usd
CY2023Q2 qind Payable To The Shareholders Of The Subsidiary Quality International
PayableToTheShareholdersOfTheSubsidiaryQualityInternational
80500000 usd
CY2023Q3 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
5033333 usd
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
63600 usd
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
23500 usd
CY2023Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
81048020 usd
CY2023Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
81436536 usd
CY2023Q3 us-gaap Loans Payable
LoansPayable
75500000 usd
CY2023Q3 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
3000000 usd
CY2023Q3 us-gaap Excess Stock Shares Issued
ExcessStockSharesIssued
6410971 shares
CY2023Q3 us-gaap Dividends Common Stock
DividendsCommonStock
2000000 usd
CY2023Q3 us-gaap Investment Company Committed Capital
InvestmentCompanyCommittedCapital
2000000 usd
CY2023Q2 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
18911641 usd
CY2023Q3 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
19055041 usd
CY2023Q3 us-gaap Asset Acquisition Contingent Consideration Liability
AssetAcquisitionContingentConsiderationLiability
35500000 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
48985895 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
41009707 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1206547 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2289614 usd
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
50192442 usd
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
43299321 usd
CY2023Q3 us-gaap Deferred Long Term Liability Charges
DeferredLongTermLiabilityCharges
27242714 usd
CY2023Q2 us-gaap Deferred Long Term Liability Charges
DeferredLongTermLiabilityCharges
28351008 usd
CY2023Q3 us-gaap Asset Acquisition Contingent Consideration Liability
AssetAcquisitionContingentConsiderationLiability
35500000 usd
CY2023Q3 us-gaap Federal Home Loan Bank Advances Long Term
FederalHomeLoanBankAdvancesLongTerm
10768392 usd
CY2023Q2 us-gaap Federal Home Loan Bank Advances Long Term
FederalHomeLoanBankAdvancesLongTerm
10761062 usd
CY2023Q3 us-gaap Asset Acquisition Consideration Transferred
AssetAcquisitionConsiderationTransferred
55000000 usd
CY2023Q3 us-gaap Postemployment Benefits Liability Noncurrent
PostemploymentBenefitsLiabilityNoncurrent
1938281 usd
CY2023Q2 us-gaap Postemployment Benefits Liability Noncurrent
PostemploymentBenefitsLiabilityNoncurrent
1938281 usd
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1938281 usd
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1938281 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
200000 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.58
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
50000 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
3.5
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
126887936 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
126887936 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
114576965 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
114576965 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
2000000 usd
CY2023Q3 us-gaap Payments For Fees
PaymentsForFees
2000000 usd
CY2022Q4 qind Net Assets
NetAssets
49255718 usd
CY2023Q3 us-gaap Goodwill
Goodwill
56387027 usd
CY2023Q3 qind Percent Earnings Of Subsidiary Transferred To Minority Interest
PercentEarningsOfSubsidiaryTransferredToMinorityInterest
0.48 pure
CY2023 us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
3828121 usd
CY2022 us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
2709626 usd
CY2023 us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
79030 usd
CY2022 us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
93670 usd
CY2023 us-gaap Legal Fees
LegalFees
285708 usd
CY2022 us-gaap Legal Fees
LegalFees
216610 usd
CY2023 us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
15454 usd
CY2022 us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
27066 usd
CY2023 us-gaap Noninterest Expense Printing And Fulfillment
NoninterestExpensePrintingAndFulfillment
3267 usd
CY2022 us-gaap Noninterest Expense Printing And Fulfillment
NoninterestExpensePrintingAndFulfillment
3872 usd
CY2023 us-gaap Professional Fees
ProfessionalFees
617273 usd
CY2022 us-gaap Professional Fees
ProfessionalFees
235385 usd
CY2023 us-gaap Proceeds From Insurance Settlement Operating Activities
ProceedsFromInsuranceSettlementOperatingActivities
15000 usd
CY2022 us-gaap Proceeds From Insurance Settlement Operating Activities
ProceedsFromInsuranceSettlementOperatingActivities
17236 usd
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18864 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
26377 usd
CY2023 us-gaap Utilities Operating Expense Maintenance
UtilitiesOperatingExpenseMaintenance
9139 usd
CY2022 us-gaap Utilities Operating Expense Maintenance
UtilitiesOperatingExpenseMaintenance
16547 usd
CY2023 us-gaap Other General Expense
OtherGeneralExpense
33171 usd
CY2022 us-gaap Other General Expense
OtherGeneralExpense
101345 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4287754 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3203268 usd
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
1512000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
222071 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q3 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
usd
CY2022Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
usd
CY2022Q3 us-gaap Other Income
OtherIncome
usd
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2023Q3 qind Receivable With Imputed Interest Reclassed To Accrued Interest Value
ReceivableWithImputedInterestReclassedToAccruedInterestValue
usd
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
usd
CY2023Q3 qind Stock Issued During Period Value Issued For Services2
StockIssuedDuringPeriodValueIssuedForServices2
usd
CY2022Q3 qind Stock Issued During Period Value Issued For Services2
StockIssuedDuringPeriodValueIssuedForServices2
usd
CY2023Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
usd
CY2022Q3 us-gaap Other Noncash Income Tax Expense
OtherNoncashIncomeTaxExpense
usd
CY2022Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
CY2022Q3 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
usd
CY2023Q2 qind Buy Back Commitments
BuyBackCommitments
usd
us-gaap Cost Of Goods And Services Sold Depreciation
CostOfGoodsAndServicesSoldDepreciation
usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold Depreciation
CostOfGoodsAndServicesSoldDepreciation
usd
CY2023Q2 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
usd
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
usd
CY2023Q3 qind Sale Of Scrap
SaleOfScrap
usd
CY2023Q3 dei Amendment Flag
AmendmentFlag
false
CY2023Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2023Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q3 dei Entity Central Index Key
EntityCentralIndexKey
0001393781

Files In Submission

Name View Source Status
f10q0923_qualityindust_htm.xml Edgar Link completed
qind-20230930_cal.xml Edgar Link unprocessable
qind-20230930_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
0001213900-23-088845-index-headers.html Edgar Link pending
0001213900-23-088845-index.html Edgar Link pending
0001213900-23-088845.txt Edgar Link pending
0001213900-23-088845-xbrl.zip Edgar Link pending
f10q0923ex31-1_quality.htm Edgar Link pending
f10q0923ex31-2_quality.htm Edgar Link pending
f10q0923ex32-1_quality.htm Edgar Link pending
f10q0923_qualityindust.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
qind-20230930.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
qind-20230930_def.xml Edgar Link unprocessable
qind-20230930_pre.xml Edgar Link unprocessable
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending